Columbia University Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2021

  1. Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance

    Nature Communications, Vol. 12, Núm. 1

2016

  1. Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/TRAIL-Cisplatin combination therapy in cervical cancer

    Genes Chromosomes and Cancer, Vol. 55, Núm. 2, pp. 177-189

2009

  1. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer

    Genes Chromosomes and Cancer, Vol. 48, Núm. 11, pp. 983-992

2008

  1. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression

    Genes Chromosomes and Cancer, Vol. 47, Núm. 9, pp. 755-765

  2. Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha.

    Molecular cancer, Vol. 7, pp. 58

2007

  1. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes

    Genes Chromosomes and Cancer, Vol. 46, Núm. 4, pp. 373-384